Immune Modulation Flashcards
Types of Immune Modulation
Vaccination
Replacement
Suppression
Sensitisation
Vaccination mechanism
Memory lymphocyte production → rapid polyclonal expansion of adaptive immune response
Active vs Passive Vaccination
Active - your own body produces response - long-term protection
Passive - pre-formed antibodies given - around 3 weeks
What are Dendritic cell vaccines
Summarise Paediatric vaccination schedule
Regular adult vaccinations
Key travel vaccines
2 non-travel vaccines that are given based on risk
4 Types of Vaccine
Live attenuated
Inactivated/component/toxoid
Conjugate
DNA/RNA
What is a live attenuated vaccine?
Give examples
Modified pathogen to limit pathogenesis
E.g. MMR-VBOY
Inactivated vaccine examples
Influenza (quadrivalent),
Polio (Salk),
Cholera,
Bubonic plague,
Hep A,
Rabies, Pertussis
Component vaccine examples
Hep B [HbS antigen],
HPV [Capsid],
Influenza recombinant quadrivalent) [haemagglutinin, neuraminidase]
Toxoid vaccine examples
Diptheria
Tetanus
Conjugate vaccine examples
NHS
Tetanus
DNA/RNA vaccine examples
SARS-CoV-2
What does an adjuvant do in vaccination?
Increases immune response without altering specificity
2 Main types of adjuvant
Depot
Stimulatory
How does a depot adjuvant work?
Slows antigen release → increased exposure to antigen → promotes immune response
Depot adjuvant example
ALUM
How does a stimulatory adjuvant work?
Mimics the action of PAMPs on TLR and PRRs → increased receptor activation → boosted immune response
Stimulatory adjuvant example
CpG
Types of Immune Replacement
Haematopoietic SCT
Ab replacement - specific/unspecific
Adoptive T cell transfer
Types of adoptive T cell transfer
Virus specific T cells
TIL T cell therapy
TCR
CAR-T cell therapy
Describe TIL T cell therapy
TILs from tumour → expanded with IL2 → infused into lymphoid depleted patient → destroys cancer cells
Describe CAR-T cell therapy
Chimeric receptor targets CD19 → greater immune response to tumour than TCR therapy
for ALL, NHL
1/2 life of normal human IVIG
18 days
Examples of recombinant cytokines
IL-2
IFN-alpha
IFN-beta
IFN-gamma
Recomobinant IL-2 uses
Renal cancer
(IL-2 2 kidneys)
IFN-alpha uses
Viruses - Hep B & C (ABC)
Cancer
IFN-beta uses
Relapsing remitting MS
IFN-gamma uses
CGD
Immune Checkpoint blockade drugs
Ipilimumab
Pembrolizumab
Nivolumab
Immune checkpoint blockade indications
Advanced melanoma
Metastatic renal cancer
Ipilimumab mechanism
Normally: CD80 and CD86 (APCs) interact with CTLA4 (inhibitory) and CD28 (stimulatory)
CTLA4 inhibitor → blocks CTLA4, all APC interactions now through CD28 → boosted T cell response
Pembrolizumab/nivolumab mechanism
PD-1 (prevent death-1) blocker monoclonal antibody
Normally, cancer cells bind PDL-1 to Treg PD-1 → prevents Treg cell killing of tumour cell
PD-1 blockade prevents binding of PDL-1 to PD-1 → enabling Treg cell killing of tumour cell
3 signals in naive T cell priming
Activation: MHC-TCR interaction
Survival: CD86/B7-CD28 interaction
Differentiation: cytokines
What are the adverse effects of immunosuppressive drugs?
Infusion reaction (IgE)
Injection reaction
Acute infection
Chronic infection
Malignancy
Autoimmunity